Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Cytomx Thera (CTMX)

Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
CytomX Therapeutics Announces First Patient Dosed in Combination Arm of Phase 1 Study of CX-801 plus KEYTRUDA® (pembrolizumab) in Patients with Metastatic Melanoma GlobeNewswire - Mon May 19, 7:00AM CDT

CTMX : 2.23 (+4.69%)
CytomX Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock GlobeNewswire - Mon May 12, 5:50AM CDT

CTMX : 2.23 (+4.69%)
CytomX Therapeutics: Q1 Earnings Snapshot AP - Mon May 12, 5:22AM CDT

CytomX Therapeutics: Q1 Earnings Snapshot

CTMX : 2.23 (+4.69%)
CytomX Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update GlobeNewswire - Mon May 12, 5:15AM CDT

CTMX : 2.23 (+4.69%)
CytomX Announces Positive Interim Data From Phase 1 Dose Escalation Study of EpCAM Antibody Drug Conjugate (CX-2051) Candidate in Patients with Advanced Colorectal Cancer (CRC) GlobeNewswire - Mon May 12, 5:15AM CDT

CTMX : 2.23 (+4.69%)
CytomX Therapeutics to Report First Quarter 2025 Financial Results on May 12, 2025 GlobeNewswire - Mon May 5, 7:00AM CDT

CTMX : 2.23 (+4.69%)
CytomX Therapeutics Presents Preclinical Data for mRNA Encoded Masked IL-12 Molecule in Collaboration with Moderna at AACR Annual Meeting GlobeNewswire - Mon Apr 28, 3:00PM CDT

CTMX : 2.23 (+4.69%)
Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips
Viking Therapeutics Q1 Loss Wider Than Expected, Sales Nil, Stock Dips Zacks Investment Research - Thu Apr 24, 1:36PM CDT

Viking Therapeutics VKTX reported a first-quarter 2025 loss of 41 cents per share, wider than the Zacks Consensus Estimate of a loss of 34 cents. The company had incurred a loss of 26 cents in the year-ago...

VKTX : 26.98 (-2.70%)
CTMX : 2.23 (+4.69%)
ETNB : 9.49 (-1.66%)
ANIP : 57.79 (+0.91%)
VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study
VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study Zacks Investment Research - Thu Apr 10, 7:04AM CDT

Shares of Valneva VALN rose 12% on Wednesday after the company announced that it has vaccinated the first participant in a phase II study evaluating its investigational Shigella vaccine, Shigella4V2 (S4V2).This...

CTMX : 2.23 (+4.69%)
ETNB : 9.49 (-1.66%)
VALN : 6.18 (-2.37%)
ANIP : 57.79 (+0.91%)
FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug
FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug Zacks Investment Research - Tue Apr 8, 7:04AM CDT

Allogene Therapeutics ALLO announced that the FDA has granted three fast track designations to its investigational CRISPR-based allogeneic CAR-T therapy, ALLO-329.These designations apply to three autoimmune...

ALLO : 1.0600 (-2.75%)
CTMX : 2.23 (+4.69%)
ETNB : 9.49 (-1.66%)
ANIP : 57.79 (+0.91%)

Barchart Exclusives

3 Highest-Yielding Dividend Stocks Worth Buying Today Barchart - Fri May 23, 6:00PM CDT
Want high-yield dividends without the risk? These three income-generating stocks offer up to 5.5% yield and strong upside, backed by Wall Street buy ratings. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot